Global Diversity of Norovirus Genotypes from 2002 to 2025: A Review of Temporal, Age-Specific and Regional Trends.
- 1Epidemiologic Research & Methods, LLC, Southport, NC 28641, USA.
- 2Moderna, Inc., Cambridge, MA 02142, USA.
- 3Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
Abstract
Norovirus is a leading cause of acute gastroenteritis (AGE) worldwide, with significant morbidity and mortality, particularly in young children and older adults. This study characterizes the global prevalence and diversity of norovirus genotypes among sporadic cases. A review of English-language studies (published 2002-2026) that characterized norovirus genotype distribution among sporadic cases was conducted, excluding outbreak and asymptomatic detections. Pooled data were analyzed with stratifications by age group, region, and year of sample collection. A total of 20,588 cases were identified from 72 publications. There were 30 genotypes identified, with GII.4, GII.3, GII.2, GII.17, and GII.6 and each accounting for ≥5% of detections. GII.4 was the predominant genotype globally, accounting for 54% of cases and up to 80% among older adults across all years, but periodic fluctuation was seen, coinciding with fluctuations in the prevalence of other genotypes, especially GII.3, GII.2, and GII.17. Among GI genotypes, GI.3 was most prevalent (46%), particularly among adults. Genotype diversity was highest among children in low- and middle-income countries and in Asia/Oceania. Findings indicate that a small number of genotypes account for most cases. As genotyping characterizes the major capsid protein, the primary target of antibody recognition, findings have important implications for vaccine development and public health interventions.
Related
- Overview of Total Knee Arthroplasty in Brazil: Regional Distribution and Temporal Evolution (2015-2025)
- Temporal trends and regional disparities in mortality from acute myocardial infarction in Brazil: a time series study, 2015-2024.
- Seroprevalence of Swine Influenza A Virus (swIAV) in Commercial Pig Farms in Greece (2023-2026): Age, Regional and Temporal Patterns.
- Hospital-Based Incidence Trends of Thyroid Cancer in Poland: Temporal Trends, Regional Disparities and Demographic Characteristics Based on a Nationwide Hospital Discharge Database (2012-2024).
- Suicide mortality in Kazakhstan from 2012 to 2024: temporal trends, demographic inequalities, and regional variation
BibTeX
@article{cannon2026global,
title = {{Global Diversity of Norovirus Genotypes from 2002 to 2025: A Review of Temporal, Age-Specific and Regional Trends.}},
author = {Jennifer L Cannon and Christine Kim and Duncan Mahood and Brooke A Bollman and Guha Asthagiri Arunkumar and Benjamin A Lopman and Katherine B Carlson},
journal = {Viruses},
year = {2026},
month = oct,
doi = {10.3390/v18101083},
url = {https://europepmc.org/article/MED/42944003},
note = {CC BY},
}
RIS
TY - JOUR
TI - Global Diversity of Norovirus Genotypes from 2002 to 2025: A Review of Temporal, Age-Specific and Regional Trends.
AU - Jennifer L Cannon
AU - Christine Kim
AU - Duncan Mahood
AU - Brooke A Bollman
AU - Guha Asthagiri Arunkumar
AU - Benjamin A Lopman
AU - Katherine B Carlson
PY - 2026
DA - 2026/10/01
JO - Viruses
DO - 10.3390/v18101083
UR - https://europepmc.org/article/MED/42944003
AB - Norovirus is a leading cause of acute gastroenteritis (AGE) worldwide, with significant morbidity and mortality, particularly in young children and older adults. This study characterizes the global prevalence and diversity of norovirus genotypes among sporadic cases. A review of English-language studies (published 2002-2026) that characterized norovirus genotype distribution among sporadic cases was conducted, excluding outbreak and asymptomatic detections. Pooled data were analyzed with stratifications by age group, region, and year of sample collection. A total of 20,588 cases were identified from 72 publications. There were 30 genotypes identified, with GII.4, GII.3, GII.2, GII.17, and GII.6 and each accounting for ≥5% of detections. GII.4 was the predominant genotype globally, accounting for 54% of cases and up to 80% among older adults across all years, but periodic fluctuation was seen, coinciding with fluctuations in the prevalence of other genotypes, especially GII.3, GII.2, and GII.17. Among GI genotypes, GI.3 was most prevalent (46%), particularly among adults. Genotype diversity was highest among children in low- and middle-income countries and in Asia/Oceania. Findings indicate that a small number of genotypes account for most cases. As genotyping characterizes the major capsid protein, the primary target of antibody recognition, findings have important implications for vaccine development and public health interventions.
SN - 1999-4915
ER -